090-70-0063

hr HPV and 16/18, PCR, Source Specify

1. Rectal Swab/Universal Transport Media (UTM) 3 mL, 1 tube or
2. Throat Swab/Universal Transport Media (UTM) 3 mL, 1 tube or
3. Vaginal Swab/ PreservCyt®
(ThinPrep liquid PAP vial) 20 mL, 1 vial

1. Rectal Swab or
2. Throat Swab or
3. Vaginal Swab 

Universal Transport Media (UTM) tube or Plastic tube

1. Specimen appear bloody or have a dark brown color
2. Specimen tubes with no swabs 
3. PreservCyt®solution volume less than minimum volume 3 mL will be reject.

1. At 2-8°C for up to 1 week
2. At temperature, 2oC to 30oC for up to 3 months 
 

090-70-0063

hr HPV and 16/18, PCR, Source Specify

Test daily, at 10:00 a.m.

Received specimen to reported within 2 days.

Molecular biology, Laboratory Department Tel.14168

1. 7 days
2. 30 days

090-70-0063

hr HPV and 16/18, PCR, Source Specify

Genital human papillomavirus (HPV) is a common virus.  Approximately 40 different HPV types  that are passed on through sexual contact. These types can infect the genital areas of men, including the skin on and around the penis or anus. HPV is passed on through genital contact most often during vaginal and anal sex. Since HPV usually causes no symptoms, most men and women can get HPV and pass it on. Most men who get HPV (of any type) never develop any symptoms or health problems. But low risk types of HPV can cause genital warts. Other types (high risk types) can cause cancers of the penis, anus, or oropharynx (back of the throat, including base of the tongue and tonsils.) 
 

HPV 16  Negative
HPV 18  Negative
Other high risk HPV genotypes  Negative

1. A positive result indicates the presence of human papillomavirus (HPV) DNA due to 1 or more of the following genotypes: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.
A negative result indicates the absence of HPV DNA of the targeted genotypes.
2. Reliable results are dependent on adequate specimen collection, transport, storage and processing procedures.
3. The detection of HPV is dependent on the number of organisms present in the specimen and may be affected by specimen collection methods, patient factors, stage of infection and/or infecting HPV genotype.
4. Mutations or polymorphisms in primer- or probe-binding regions may affect detection of HPV DNA, resulting in a false negative result.
 

Manufacturer’s package insert, cobas® HPV Qualitative nucleic acid test for use on the cobas® 6800/8800 SystemsTest, November 2022, Roche Molecular Systems, NJ 08876 Branchburg, USA.